Hendrikus J. Dubbink

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 111 publications

The potential clinical benefit of routine comprehensive genomic profiling in non-small cell lung cancer for the detection of prognostic co-mutations - A multicenter next generation sequencing study.

The potential clinical benefit of routine comprehensive genomic profiling in non-small cell lung cancer for the detection of prognostic co-mutations - A multicenter next generation sequencing study.

Journal: Cancer treatment and research communications

Published: December 17, 2025

End of a diagnostic odyssey: the added value of multi-tissue analysis in the identification of mosaicism in tumour predisposition syndromes.

End of a diagnostic odyssey: the added value of multi-tissue analysis in the identification of mosaicism in tumour predisposition syndromes.

Journal: Journal of medical genetics

Published: September 29, 2025

Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trial.

Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trial.

Journal: The Lancet. Oncology

Published: July 13, 2025

Determining the optimal approach to identify osimertinib resistance; the first line osimertinib cohort of the OSIRIS study.

Determining the optimal approach to identify osimertinib resistance; the first line osimertinib cohort of the OSIRIS study.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: June 24, 2025

Prospective clinical evaluation of cell-free DNA next generation sequencing in patients with suspected metastatic lung cancer.

Prospective clinical evaluation of cell-free DNA next generation sequencing in patients with suspected metastatic lung cancer.

Journal: Scientific reports

Published: April 30, 2025

Yield of next-generation sequencing in diagnostic work up of suspicious biliary strictures.

Yield of next-generation sequencing in diagnostic work up of suspicious biliary strictures.

Journal: Endoscopy international open

Published: March 04, 2025

Utilizing ctDNA to discover mechanisms of resistance to targeted therapies in patients with metastatic NSCLC: towards more informative trials.

Utilizing ctDNA to discover mechanisms of resistance to targeted therapies in patients with metastatic NSCLC: towards more informative trials.

Journal: Nature reviews. Clinical oncology

Published: February 27, 2025

Analytical Validation of a Pan-Cancer Next-Generation Sequencing Assay for In-House Liquid Biopsy Testing: An International Multicenter Study.

Analytical Validation of a Pan-Cancer Next-Generation Sequencing Assay for In-House Liquid Biopsy Testing: An International Multicenter Study.

Journal: The Journal of molecular diagnostics : JMD

Published: January 18, 2025

Analysis of comprehensive genomic profiling of solid tumors with a novel assay for broad analysis in clinical diagnostics.

Analysis of comprehensive genomic profiling of solid tumors with a novel assay for broad analysis in clinical diagnostics.

Journal: Molecular oncology

Published: August 27, 2024

A Response to the Letter to the Editor: Comment on "Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRAS(G12C)-Mutated NSCLC Treated With Sotorasib".

A Response to the Letter to the Editor: Comment on "Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRAS(G12C)-Mutated NSCLC Treated With Sotorasib".

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: July 04, 2024

Letter Regarding "Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRASG12C-Mutated NSCLC Treated With Sotorasib".

Letter Regarding "Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRASG12C-Mutated NSCLC Treated With Sotorasib".

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: June 13, 2024

Molecular Tumor Board of the University Medical Center Groningen (UMCG-MTB): outcome of patients with rare or complex mutational profiles receiving MTB-advised targeted therapy.

Molecular Tumor Board of the University Medical Center Groningen (UMCG-MTB): outcome of patients with rare or complex mutational profiles receiving MTB-advised targeted therapy.

Journal: ESMO open

Published: May 24, 2024

Showing 1-12 of 111

Last Updated: 09/26/2026